Cargando…
The first successful desensitization protocol in exenatide allergy: a case report
BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are important treatment options in obese patients with type 2 diabetes. To date, few immediate allergic reactions due to GLP-1 receptor agonists were reported. One report revealed that a patient with a level 1 anaphylaxis according to Bri...
Autores principales: | Yeğit, Osman Ozan, Sarıbeyliler, Göktuğ, Karadağ, Pelin, Demir, Semra, Gül, Nurdan, Ünal, Derya, Gelincik Akkor, Aslı |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838064/ https://www.ncbi.nlm.nih.gov/pubmed/36639791 http://dx.doi.org/10.1186/s13223-023-00761-y |
Ejemplares similares
-
Comparison of recent anaphylaxis diagnostic criteria in real life: Can more patients be diagnosed as having anaphylaxis?
por: Yeğit, Osman Ozan, et al.
Publicado: (2023) -
Interleukin-10 is increased in successful drug desensitization regardless of the hypersensitivity reaction type
por: Gelincik, Aslı, et al.
Publicado: (2019) -
Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment()
por: Olgaç, Müge, et al.
Publicado: (2023) -
Impact of mental health on disease activity in mastocytosis during COVID-19 pandemic
por: Öztop, Nida, et al.
Publicado: (2022) -
Generalized Fixed Drug Eruption Induced by Fluconazole Without Cross-Reactivity to Itraconazole: Lymphocyte Transformation Test Confirms the Diagnosis
por: Demir, Semra, et al.
Publicado: (2018)